Fund Holdings — BOONE CAPITAL MANAGEMENT LLC

Total Portfolio Value:
$376.70M
Total Bought:
$106.07M
Total Sold:
$140.15M
Net Transaction:
-$34.08M
Notable People:
Daniel Walter Boone
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
BioMarin Pharmaceutical Inc.(BMRN)583,219671,998+88,779$33.37M$40.32M10.70%+$6.95M
Teleflex Incorporated(TFX)387,388288,899-98,489$49.11M$36.12M9.59%-$12.98M
Mirum Pharmaceuticals, Inc.(MIRM)415,641415,6410$48.66M$35.53M9.43%-$13.13M
UnitedHealth Group Incorporated(UNH)88,68788,6870$36.86M$32.56M8.64%-$4.31M
The Cigna Group(CI)159,290112,268-47,022$43.91M$30.52M8.10%-$13.40M
Guardian Pharmacy Services, Inc.CL A(GRDN)711,939725,061+13,122$29.81M$29.57M7.85%-$240.9K
Avantor, Inc.(AVTR)01,838,972+1,838,972$0$27.68M7.35%+$27.68M
Labcorp Holdings Inc.(LH)087,551+87,551$0$26.98M7.16%+$26.98M
Encompass Health Corporation(EHC)0205,838+205,838$0$25.01M6.64%+$25.01M
Vestis Corporation(VSTS)1,900,1401,583,652-316,488$27.59M$21.16M5.62%-$6.43M
Pennant Group Inc515,818525,916+10,098$19.06M$20.51M5.44%+$1.45M
BridgeBio Pharma, Inc.(BBIO)339,720277,433-62,287$25.30M$18.26M4.85%-$7.05M
Waystar Holding Corp.(WAY)0508,649+508,649$0$12.89M3.42%+$12.89M
Cullinan Therapeutics Inc704,442690,814-13,628$12.83M$10.60M2.81%-$2.22M
Maze Therapeutics, Inc.(MAZE)0179,495+179,495$0$4.88M1.30%+$4.88M
Adlai Nortye Group LtdADS258,390258,3900$2.97M$4.13M1.10%+$1.16M
Ionis Pharmaceuticals, Inc.(IONS)519,9770-519,977$41.23M$0—-$41.23M
Kodiak Sciences Inc.(KOD)378,0100-378,010$14.73M$0—-$14.73M
Kymera Therapeutics, Inc.(KYMR)113,1730-113,173$12.98M$0—-$12.98M
Monte Rosa Therapeutics, Inc.(GLUE)615,2870-615,287$14.89M$0—-$14.89M
Tango Therapeutics, Inc.(TNGX)455,6050-455,605$14.24M$0—-$14.24M
Page 1 of 1
BOONE CAPITAL MANAGEMENT LLC — 13F Holdings — Q3 2026 | TickerTrail